AISLING CAPITAL III LP sold 40.7% of their position (1.40M shares) of LOXO ONCOLOGY, INC. on the open market
Open‑market sale worth $251.20M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/12/2018ACC: 0000899243-18-019810
10% Owner
Since Jul 2018
-1.40M
Net shares
Net seller
$251.20M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.40M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.40M
Price / share
$179.43
Trade value
$251.20M
% of position
40.7%
7/10/2018
3.44M→2.04M
Total
Net shares
−1.40M
Net value
-$251.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2018 | S · Sale | −1.40M | $179.43 | $251.20M | 40.7% | 3.44M | 2.04M |
| Total | −1.40M | -$251.20M | ||||||
Derivative Transactions0
No derivative transactions reported